Caspofungin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00520 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 30 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gastrin secretion abnormality | KG + DL |
| 2 | punctate epithelial keratoconjunctivitis | KG + DL |
| 3 | abnormality of glucagon secretion | KG + DL |
| 4 | HIV infectious disease | KG + DL |
| 5 | feline acquired immunodeficiency syndrome | KG + DL |
| 6 | simian immunodeficiency virus infection | KG + DL |
| 7 | exposure keratitis | KG + DL |
| 8 | neonatal candidiasis | KG + DL |
| 9 | congenital candidiasis | KG + DL |
| 10 | candida glabrata | KG + DL |
| 11 | candidiasis, invasive | KG + DL |
| 12 | polyclonal hyperviscosity syndrome | KG + DL |
| 13 | hyperamylasemia | KG + DL |
| 14 | epidemic keratoconjunctivitis | KG + DL |
| 15 | blood group incompatibility | KG + DL |
| 16 | premalignant hematological system disease | KG + DL |
| 17 | congenital analbuminemia | KG + DL |
| 18 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 19 | non-human animal disease | KG + DL |
| 20 | monoclonal gammopathy | KG + DL |
| 21 | septicemic plague | KG + DL |
| 22 | disseminated candidiasis | KG + DL |
| 23 | congenital hematological disorder | KG + DL |
| 24 | hematological disease associated with an acquired peripheral neuropathy | KG + DL |
| 25 | neoplastic syndrome | KG + DL |
| 26 | staphylococcus aureus pneumonia | KG + DL |
| 27 | acne (disease) | KG + DL |
| 28 | candidiasis | KG + DL |
| 29 | staphylococcal scalded skin syndrome | KG + DL |
| 30 | leishmaniasis, diffuse cutaneous | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.